Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Conus

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Early Intervention in Psychiatry|March 1, 2011
Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristicsLisa P Henry, Meredith G Harris, G Paul Amminger, et al.
Molecular Psychiatry|March 29, 2020
Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patientsDaniella Dwir, Basilio Giangreco, Lijing Xin, et al.
Molecular Psychiatry|September 21, 2022
Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosisGiorgio Pistis, Javier Vázquez-Bourgon, Margot Fournier, et al.
Translational Psychiatry|October 8, 2021
Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Journal of Clinical Psychopharmacology|August 18, 2015
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic TreatmentsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Biological Psychiatry|April 26, 2008
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trialMichael Berk, David Copolov, Olivia Dean, et al.
Translational Psychiatry|July 6, 2021
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Schizophrenia Bulletin Open|December 13, 2021
White Matter Alterations Between Brain Network Hubs Underlie Processing Speed Impairment in Patients With SchizophreniaPaul Klauser, Vanessa L Cropley, Philipp S Baumann, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Transdiagnostic clinical staging in youth mental health: a first international consensus statementJai L Shah, Jan Scott, Patrick D McGorry, et al.
Plos One|October 14, 2015
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical DepressionAurélie Delacrétaz, Martin Preisig, Frederik Vandenberghe, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Early Intervention in Psychiatry|March 1, 2011
Early Psychosis Prevention and Intervention Centre long-term follow-up study of first-episode psychosis: methodology and baseline characteristicsLisa P Henry, Meredith G Harris, G Paul Amminger, et al.
Molecular Psychiatry|March 29, 2020
Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patientsDaniella Dwir, Basilio Giangreco, Lijing Xin, et al.
Molecular Psychiatry|September 21, 2022
Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosisGiorgio Pistis, Javier Vázquez-Bourgon, Margot Fournier, et al.
Translational Psychiatry|October 8, 2021
Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Journal of Clinical Psychopharmacology|August 18, 2015
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic TreatmentsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Biological Psychiatry|April 26, 2008
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trialMichael Berk, David Copolov, Olivia Dean, et al.
Translational Psychiatry|July 6, 2021
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohortCéline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, et al.
Schizophrenia Bulletin Open|December 13, 2021
White Matter Alterations Between Brain Network Hubs Underlie Processing Speed Impairment in Patients With SchizophreniaPaul Klauser, Vanessa L Cropley, Philipp S Baumann, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 13, 2020
Transdiagnostic clinical staging in youth mental health: a first international consensus statementJai L Shah, Jan Scott, Patrick D McGorry, et al.
Plos One|October 14, 2015
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical DepressionAurélie Delacrétaz, Martin Preisig, Frederik Vandenberghe, et al.
Pageof 29